ERBITUX 500 Mg INJECTION


prescription Prescription Required

Salt Composition

:     Cetuximab

Manufacturer

:     Merck Ltd

Origin of Medicine

:     United States of America

Indication

:     Metastatic colorectal cancer, Squamous cell cancer head and neck

Packaging

:     1 Vial(S) Of 05ml

Dosage Form

:     Injection

MRP

  :     ₹ 101110

(Save Upto 40%)



Erbitux 500mg injection is an anticancer medication containing the active ingredient Cetuximab which belongs to the class of medicine called a monoclonal antibody.

It is used to treat metastatic cancer of the large intestine either alone or with a combination of their medicine. Additionally, it is also used to treat certain types of squamous cell cancer of the head and neck.

Erbitux 500mg Infusion is given as an injection under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time.

Your doctor will take a blood test to monitor your WBC count; because there is a chance of reducing WBC counts while taking this medicine with a combination of anticancer medicine (platinum-based therapy).

Before taking it, tell your doctor if you have heart disease, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using.

MEDICINAL USE OF ERBITUX INJECTION
  • Metastatic colorectal cancer
  • Squamous cell cancer head and neck

Erbitux 500mg binds to the protein called epidermal growth factor receptor (EFGR). As a result of this binding, cancer cells no longer receive the signal that the cells need for growth and development. Thus, this medication prevents cancer cells from growing.

SIDE EFFECTS OF ERBITUX INJECTION

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

  • Nausea, vomiting
  • Diarrhea
  • Skin Reactions
  • Headache
  • Low magnesium levels
  • Infections
  • Dizziness
  • Cough
  • Unusual tiredness or weakness
  • Infusion reactions (swelling of face, eyes, mouth, throat, or lips, difficulty breathing, wheezing, chest pain, fainting, or fever)
  • Heart problems
  • Blistering or peeling of skin
  • Vision problems
  • Diarrhea, constipation
  • Weight loss, poor appetite
  • Nausea, vomiting
DOSAGE USE OF ERBITUX INJECTION
  • The initial and subsequent doses of Erbitux 500mg injection is 500 mg/m2 administered as a 120-minute intravenous infusion every 2 weeks12.
  • Your doctor will decide what dose is necessary for you based on your medical condition and response to treatment3.
  • Erbitux 500mg Infusion is given as an injection into the veins under the supervision of a doctor.
Ques 1. : Is Erbitux 500mg Infusion a chemotherapy drug?

Ans : Yes, Erbitux 500mg Infusion is a cytotoxic drug that is used in the chemotherapy of cancers of colon and rectum, and head-neck cancers.

Ques 2. : Is Erbitux 500mg Infusion cytotoxic agent or vesicant or radiosensitizer?

Ans : It is not a radiosensitizer, but usually used in combination with radiotherapy to treat the cancers. It is not a vesicant (irritant).

Ques 3. : How is Erbitux 500mg Infusion administered?

Ans :Erbitux 500mg Infusion is generally administered by intravenous (IV infusion) route, with or without radiotherapy.

Ques 4. : Does Erbitux 500mg Infusion cause hair loss?

Ans : Yes. Erbitux 500mg Infusion is a chemotherapy agent, which may cause hair loss. Please consult your doctor if you experience such side effect.

Ques 5. : Can Erbitux 500mg be used in combination with other cancer treatments?

Ans : Yes, Erbitux 500mg is often used in combination with radiation therapy or chemotherapy to treat certain types of cancer.

Ques 6. : What is the difference between Erbitux 500mg and other cancer treatments?

Ans : Erbitux 500mg is a targeted therapy that specifically targets cancer cells with high levels of EGFR. It is different from chemotherapy and radiation therapy, which target both cancer and healthy cells.

<